{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:07:18Z","timestamp":1788926838898,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,8]]},"DOI":"10.7759\/cureus.115974","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:48:18Z","timestamp":1788925698000},"source":"Crossref","is-referenced-by-count":0,"title":["Proton Pump Inhibitor-Associated Hypomagnesemia: A Case Report Highlighting a Rare Adverse Effect"],"prefix":"10.7759","author":[{"given":"Hugo","family":"Sabillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0724-1","article-title":"Inhibiting the proton pump: mechanisms, benefits, harms, and questions","volume":"14","author":"Aronson JK","year":"2016","unstructured":"Aronson JK. Inhibiting the proton pump: mechanisms, benefits, harms, and questions. BMC Med. 2016, 14:172. 10.1186\/s12916-016-0724-1","journal-title":"BMC Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0532-9","article-title":"A review of the novel application and potential adverse effects of proton pump inhibitors","volume":"34","author":"Yu LY","year":"2017","unstructured":"Yu LY, Sun LN, Zhang XH, et al.. A review of the novel application and potential adverse effects of proton pump inhibitors. Adv Ther. 2017, 34:1070-86. 10.1007\/s12325-017-0532-9","journal-title":"Adv Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13846","article-title":"Mechanisms of proton pump inhibitor-induced hypomagnesemia","volume":"235","author":"Gommers LM","year":"2022","unstructured":"Gommers LM, Hoenderop JG, de Baaij JH. Mechanisms of proton pump inhibitor-induced hypomagnesemia. Acta Physiol (Oxf). 2022, 235:e13846. 10.1111\/apha.13846","journal-title":"Acta Physiol (Oxf)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.829","article-title":"An overview of diagnosis and management of drug-induced hypomagnesemia","volume":"9","author":"Liamis G","year":"2021","unstructured":"Liamis G, Hoorn EJ, Florentin M, Milionis H. An overview of diagnosis and management of drug-induced hypomagnesemia. Pharmacol Res Perspect. 2021, 9:e00829. 10.1002\/prp2.829","journal-title":"Pharmacol Res Perspect"},{"key":"ref5","article-title":"Adverse Drug Reaction Probability Scale (Naranjo) in drug induced liver injury","author":"National Institute of Diabetes and Digestive and Kidney Diseases","year":"2019","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. Adverse Drug Reaction Probability Scale (Naranjo) in drug induced liver injury. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD); 2019."},{"key":"ref6","article-title":"","author":"World Health Organization","year":"2002","unstructured":"World Health Organization. Safety of Medicines: A Guide to Detecting and Reporting Adverse Drug Reactions: Why Health Professionals Need to Take Action. World Health Organization, Geneva, Switzerland; 2002. https:\/\/www.who.int\/publications\/i\/item\/WHO-EDM-QSM-2002-2."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease","volume":"117","author":"Katz PO","year":"2022","unstructured":"Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022, 117:27-56. 10.14309\/ajg.0000000000001538","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg DE","year":"2017","unstructured":"Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017, 152:706-15. 10.1053\/j.gastro.2017.01.031","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510603","article-title":"Magnesium disorders","volume":"390","author":"Touyz RM","year":"2024","unstructured":"Touyz RM, de Baaij JH, Hoenderop JG. Magnesium disorders. N Engl J Med. 2024, 390:1998-2009. 10.1056\/NEJMra1510603","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-018-0291-y","article-title":"Hypomagnesemia in critically ill patients","volume":"6","author":"Hansen BA","year":"2018","unstructured":"Hansen BA, Bruserud \u00d8. Hypomagnesemia in critically ill patients. J Intensive Care. 2018, 6:21. 10.1186\/s40560-018-0291-y","journal-title":"J Intensive Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-0537","article-title":"Improving diagnosis and treatment of hypomagnesemia","volume":"62","author":"Salinas M","year":"2024","unstructured":"Salinas M, L\u00f3pez-Garrig\u00f3s M, Flores E, Leiva-Salinas C. Improving diagnosis and treatment of hypomagnesemia. Clin Chem Lab Med. 2024, 62:234-48. 10.1515\/cclm-2023-0537","journal-title":"Clin Chem Lab Med"},{"key":"ref12","unstructured":"FDA. NEXIUM (esomeprazole magnesium) delayed-release capsules and delayed-release oral suspension: prescribing information. (2023). Accessed: September 6, 2026: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/021153s060%2C021957s027%2C022101s024lbl.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/951768","article-title":"Hypomagnesemia induced by long-term treatment with proton-pump inhibitors","volume":"2015","author":"Janett S","year":"2015","unstructured":"Janett S, Camozzi P, Peeters GG, et al.. Hypomagnesemia induced by long-term treatment with proton-pump inhibitors. Gastroenterol Res Pract. 2015, 2015:951768. 10.1155\/2015\/951768","journal-title":"Gastroenterol Res Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/401461-proton-pump-inhibitor-associated-hypomagnesemia-a-case-report-highlighting-a-rare-adverse-effect","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:48:22Z","timestamp":1788925702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/401461-proton-pump-inhibitor-associated-hypomagnesemia-a-case-report-highlighting-a-rare-adverse-effect"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.115974","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,8]]}}}